• ALEXZA PHARMACEUTICALS INC Profile

    Alexza Pharmaceuticals has found that some good can come out of smoking cigarettes. Though they deliver harmful chemicals, cigarettes deliver those chemicals almost instantly. That is the basis for Alexza Pharmaceutical's primary product, Staccato inhalers. The inhalers contain a heating element coated with a thin layer of medicine. Before use, the patient triggers the heating element which vaporizes the medicine, allowing the patient to inhale it. The medicine is then rapidly absorbed through the lungs at a rate typically faster than oral and intravenous mediations. The company has been targeting acute pain treatments and anxiety treatments.
    Thomas B. King
    CEO
    2091 Stierlin Court

    Mountain View, CA 94043

    http://www.alexza.com

    Phone: 650-944-7000

    Fax: 650-944-7999
    Sector: Healthcare Industry: Drugs
  • 2006 Sales 2006 Sales Growth 2006 Net Income 2006 Employees
    $1,000,000 -53.8% $-41,800,000 141
  • Key Executives: ALXA

    Name Title Officer Since
    Thomas B. King CEO 6/1/03
    August J. Moretti CFO -
    Dr. Deepika R. Pakianathan, Ph.D. Director 11/1/04
    Dr. J. Leighton Read, M.D. Director 11/1/04
    Dr. Gordon Ringold, Ph.D. Director 6/1/01
    Alejandro A. Zaffaroni, M.D. -
    Isaac Stein, J.D. Director 6/1/01
    Alan D. Frazier Director 9/1/02
  • Top Competitors: ALXA

  • Insider Trends: ALXA

    Sentiment for ALXA is NEGATIVE

    • 0M
    • 2M
    • 4M
    • 6M
    • Market Value of Insider Sales
    • Market Value of Insider Purchases
    Total dollar value of all insider purchases and sales over 12 months
  • Insider Transactions: ALXA

    Date Name Shares Transaction Type Market Value
    05/15/08 RINGOLD GORDON 7,000 Purchase $41,720.00
    05/12/08 KING THOMAS BRAXTON 12,500 Planned Sale $76,476.30
    05/12/08 KING THOMAS BRAXTON 12,500 Sale $76,476.00
  • Ownership Breakdown : ALXA

    Large Block Holder Type Number  
    Institutions 66.00
     
    Mutual Fund 85.00
    Other Major 11.00
  • Short Interest Volume: ALXA

    Data as of 6/25/08
    Current Short Interest Shares 301.99 M
    Current Short Interest Ratio 16.40
    Float 30.42 M
    Short Interest as % of Float 8.40
    Average Daily Volume 148,000.00
    Outstanding Shares 32.58 M